Online citations, reference lists, and bibliographies.
← Back to Search

Aerosol Delivery Of SiRNA To The Lungs. Part 2: Nanocarrier-based Delivery Systems.

Susanne R. Youngren-Ortiz, N. S. Gandhi, L. España-Serrano, M. Chougule
Published 2017 · Materials Science, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
In this article, applications of engineered nanoparticles containing siRNA for inhalation delivery are reviewed and discussed. Diseases with identified protein malfunctions may be mitigated through the use of well-designed siRNA therapeutics. The inhalation route of administration provides local delivery of siRNA therapeutics to the lungs for various pulmonary diseases. A siRNA delivery system can be used to overcome the barriers of pulmonary delivery, such as anatomical barriers, mucociliary clearance, cough clearance, and alveolar macrophage clearance. Apart from naked siRNA aerosol delivery, previously studied siRNA carrier systems include those of lipidic, polymeric, peptide, or inorganic origin. These delivery systems can achieve pulmonary delivery through the generation of an aerosol via an inhaler or nebulizer. The preparation methodologies for these siRNA nanocarrier systems will be discussed herein. The use of inhalable nanocarrier siRNA delivery systems have barriers to their effective delivery, but overcoming these constraints while formulating a safe and effective delivery system will offer unique advances to the field of inhaled medicine.
This paper references
10.1021/CR940534G
Atom transfer radical polymerization.
K. Matyjaszewski (2001)
10.1016/j.biomaterials.2012.05.055
Enhancing in vivo circulation and siRNA delivery with biodegradable polyethylenimine-graft-polycaprolactone-block-poly(ethylene glycol) copolymers.
M. Zheng (2012)
10.1016/S0378-5173(96)04822-3
Sterilization and freeze-drying of drug-free and drug-loaded solid lipid nanoparticles
R. Cavalli (1997)
10.1016/j.ijpharm.2011.08.012
Calcium condensed cell penetrating peptide complexes offer highly efficient, low toxicity gene silencing.
A. Baoum (2012)
10.1021/bm9004904
Cellular uptake of functional nanogels prepared by inverse miniemulsion ATRP with encapsulated proteins, carbohydrates, and gold nanoparticles.
Daniel J. Siegwart (2009)
10.1111/j.1749-6632.1995.tb44738.x
Improved Cationic Lipid Formulations for In Vivo Gene Therapy
P. Felgner (1995)
10.1016/S0168-3659(01)00519-3
Synthesis and characterization of poly(ethyl-2-cyanoacrylate) nanoparticles with a magnetic core.
J. L. Arias (2001)
10.1208/s12249-007-9024-6
Development of Spray Dried Liposomal Dry Powder Inhaler of Dapsone
M. Chougule (2007)
10.1021/mp500403b
Designing hybrid onconase nanocarriers for mesothelioma therapy: a Taguchi orthogonal array and multivariate component driven analysis.
Rakesh K Tekade (2014)
10.1021/JA044532H
Liquid-core capsules via interfacial polymerization: a free-radical analogy of the nylon rope trick.
C. Scott (2005)
10.1021/MA1009269
Surfactant-Free RAFT Emulsion Polymerization Using Poly(N,N-dimethylacrylamide) Trithiocarbonate Macromolecular Chain Transfer Agents
J. Rieger (2010)
10.1007/978-1-4615-9254-9_9
Biopolymer induced changes in mucus viscoelasticity.
C. Marriott (1982)
10.1039/B307062J
Synthetic, self-assembly ABCD nanoparticles; a structural paradigm for viable synthetic non-viral vectors.
K. Kostarelos (2005)
10.1021/nn203745n
In vivo sustained release of siRNA from solid lipid nanoparticles.
Tatsiana Lobovkina (2011)
10.1038/mt.2011.206
Uptake, efficacy, and systemic distribution of naked, inhaled short interfering RNA (siRNA) and locked nucleic acid (LNA) antisense.
S. Moschos (2011)
10.1163/156856209X415828
Co-delivery of as-miR-21 and 5-FU by Poly(amidoamine) Dendrimer Attenuates Human Glioma Cell Growth in Vitro
Y. Ren (2010)
10.1016/j.bbamem.2009.06.022
Nanoparticles evading the reticuloendothelial system: role of the supported bilayer.
Shyh-Dar Li (2009)
10.1016/j.jconrel.2009.10.010
Spray drying of siRNA-containing PLGA nanoparticles intended for inhalation
D. K. Jensen (2010)
10.1016/J.PROGPOLYMSCI.2006.11.002
Controlled/living radical polymerization: Features, developments, and perspectives
W. Braunecker (2007)
10.1038/nbt1122
Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs
David V Morrissey (2005)
Clobetasol propionate solid lipid nanoparticles cream for effective treatment of eczema: formulation and clinical implications.
Mayur Kalariya (2005)
10.1016/J.PROGPOLYMSCI.2011.01.001
Polymer nanoparticles: Preparation techniques and size-control parameters
J. D. Rao (2011)
10.1371/journal.pone.0057391
Klotho Sensitizes Human Lung Cancer Cell Line to Cisplatin via PI3k/Akt Pathway
Yan Wang (2013)
10.1002/smll.200900621
Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells.
A. M. Chen (2009)
10.1016/j.jconrel.2013.12.008
Combined delivery of HMGB-1 box A peptide and S1PLyase siRNA in animal models of acute lung injury.
Binna Oh (2014)
10.1201/9780203909362.CH11
Understanding the RESS Process
M. Weber (2002)
10.1038/nm0195-39
Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis
Natasha J. Caplen (1995)
10.3892/ijo.2013.2194
Evidence that depletion of the sorting nexin 1 by siRNA promotes HGF-induced MET endocytosis and MET phosphorylation in a gefitinib-resistant human lung cancer cell line.
Y. Nishimura (2014)
10.1021/IE0201819
Effect of Concentration and Degree of Saturation on RESS of a CO2-Soluble Fluoropolymer
A. Blasig (2002)
10.1073/pnas.0912186107
A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus
J. Devincenzo (2010)
10.1007/s11051-014-2420-4
One-pot aqueous synthesis of cysteine-capped CdTe/CdS core–shell nanowires
Y. Shan (2014)
10.1021/ar200110p
Nonviral pulmonary delivery of siRNA.
O. Merkel (2012)
10.1016/0168-3659(94)90047-7
Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization
C. Schwarz (1994)
10.1016/S0001-8686(98)00063-3
Structure, dynamics and transport properties of microemulsions
S. P. Moulik (1998)
10.1007/S10971-008-1847-4
Biodegradability of sol–gel silica microparticles for drug delivery
K. Finnie (2009)
10.1016/j.jconrel.2015.09.004
Bio-inspired materials in drug delivery: Exploring the role of pulmonary surfactant in siRNA inhalation therapy.
Lynn De Backer (2015)
10.1002/(SICI)1520-6017(200005)89:5<682::AID-JPS14>3.0.CO;2-#
Mechanisms of protection of cationic lipid-DNA complexes during lyophilization.
S. D. Allison (2000)
10.1038/mt.2013.10
Enhanced Intrapulmonary Delivery of Anticancer siRNA for Lung Cancer Therapy Using Cationic Ethylphosphocholine-based Nanolipoplexes
G. Shim (2013)
10.1021/MA0712403
Mechanistic Investigation of Particle Size Effects in TEMPO- Mediated Radical Polymerization of Styrene in Aqueous Miniemulsion
P. Zetterlund (2007)
10.1007/s11051-014-2648-z
siRNA-loaded PEGylated porous silicon nanoparticles for lung cancer therapy
S. Chen (2014)
One-pot synthesis of hairy nanoparticles by emulsion
K. Min (2009)
Agency response letter GRAS notice no
D. Keefe (2011)
10.1021/mp800157x
Controlling HBV replication in vivo by intravenous administration of triggered PEGylated siRNA-nanoparticles.
S. Carmona (2009)
10.1128/AAC.00014-09
RNA Interference-Mediated Silencing of the Respiratory Syncytial Virus Nucleocapsid Defines a Potent Antiviral Strategy
R. Alvarez (2009)
Nanoliposomal dry powder formulations
G. Patel (2009)
10.1021/MA050661M
An effective method for preparing polymer nanocapsules with hydrophobic acrylic shell and hydrophilic interior by inverse emulsion radical polymerization
D. Sarkar (2005)
10.1016/J.NANO.2005.12.003
Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles.
C. Reis (2006)
10.1021/bc800278e
siRNA conjugate delivery systems.
J. Jeong (2009)
10.1038/nbt1402
A combinatorial library of lipid-like materials for delivery of RNAi therapeutics
A. Akinc (2008)
10.3109/03639049809108571
Preparation techniques and mechanisms of formation of biodegradable nanoparticles from preformed polymers.
D. Quintanar-Guerrero (1998)
10.1261/RNA.348307
Large-scale production of dsRNA and siRNA pools for RNA interference utilizing bacteriophage ϕ6 RNA-dependent RNA polymerase
A. Aalto (2007)
10.1016/j.jconrel.2014.09.001
Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances.
N. S. Gandhi (2014)
Agency response letter GRAS notice no. GRN 000397
D Keefe (2011)
Computational insights into the interactions between DNA and siRNA with “rigid” and “flexible
G. M. Pavan (2010)
10.1042/BJ1750565
Enhancement of the viscosity of mucin by serum albumin.
S. List (1978)
Methods for preparation of drug-loaded polymeric nanoparticles, Nanomedicine: Nanotechnology
C. P. Reis (2006)
Influence of the preparation conditions on poly (ethylcyanoacrylate) nanocapsule formation, International
G. Puglisi (1995)
10.1016/j.chembiol.2011.12.008
RNA-based therapeutics: current progress and future prospects.
J. Burnett (2012)
10.1155/2013/712678
Formulation Development and Evaluation of Hybrid Nanocarrier for Cancer Therapy: Taguchi Orthogonal Array Based Design
Rakesh K Tekade (2013)
10.3109/1061186X.2011.622404
Innovative strategy for treatment of lung cancer: targeted nanotechnology-based inhalation co-delivery of anticancer drugs and siRNA
O. Taratula (2011)
10.1016/S0076-6879(09)64017-9
Chapter 17 - Engineering cationic liposome siRNA complexes for in vitro and in vivo delivery.
Jennifer E. Podesta (2009)
10.1021/JA0719780
Mesoporous silica nanoparticles for intracellular delivery of membrane-impermeable proteins.
I. Slowing (2007)
44–69 in situ miniemulsion polymerization
Susanne R. Youngren-Ortiz (2017)
10.1038/nrd2742
Knocking down barriers: advances in siRNA delivery
K. Whitehead (2009)
10.1016/j.bmcl.2010.03.109
Clinical status of duplex RNA.
J. K. Watts (2010)
10.1248/BPB.B13-00167
Gene silencing in a mouse lung metastasis model by an inhalable dry small interfering RNA powder prepared using the supercritical carbon dioxide technique.
T. Okuda (2013)
10.1016/0928-0987(94)90407-3
P234 solid lipid nanoparticles stabilized by tyloxapol
B. Siekmann (1994)
10.1006/ABBI.1997.0385
Maintenance of transfection rates and physical characterization of lipid/DNA complexes after freeze-drying and rehydration.
T. Anchordoquy (1997)
Large-scale production of dsRNA and siRNA pools for RNA interference utilizing bacteriophage phi6 RNA-dependent RNA polymerase.
A. Aalto (2007)
10.1002/biot.201100054
Current progress of siRNA/shRNA therapeutics in clinical trials
J. Burnett (2011)
10.1080/09553009514550181
A knowledge-based model of DNA hydration.
Y. Umrania (1995)
10.1371/journal.pone.0042655
Efficacy of a Novel Class of RNA Interference Therapeutic Agents
T. Hamasaki (2012)
10.1023/B:PHAM.0000036917.75634.be
Physicochemical Parameters Associated with Nanoparticle Formation in the Salting-Out, Emulsification-Diffusion, and Nanoprecipitation Methods
S. Galindo-Rodriguez (2004)
10.1016/S0169-409X(00)00116-2
Nanoparticulate systems for the delivery of antisense oligonucleotides.
G. Lambert (2001)
10.1073/PNAS.0402630101
Protection against lethal influenza virus challenge by RNA interference in vivo.
S. Tompkins (2004)
10.1023/A:1007574030674
Preparation of Biodegradable Insulin Nanocapsules from Biocompatible Microemulsions
Suchat Watnasirichaikul (2004)
10.1371/journal.pone.0052984
EZH2 Promotes Malignant Behaviors via Cell Cycle Dysregulation and Its mRNA Level Associates with Prognosis of Patient with Non-Small Cell Lung Cancer
W. Cao (2012)
10.1016/j.addr.2009.04.005
Cellular siRNA delivery using cell-penetrating peptides modified for endosomal escape.
T. Endoh (2009)
10.1002/(SICI)1097-4628(19970103)63:1<125::AID-APP13>3.0.CO;2-4
Novel hydrophilic chitosan‐polyethylene oxide nanoparticles as protein carriers
P. Calvo (1997)
10.1073/pnas.0910603106
Lipid-like materials for low-dose, in vivo gene silencing
K. Love (2010)
10.1089/jamp.2011-0966
Characterization and application of a nose-only exposure chamber for inhalation delivery of liposomal drugs and nucleic acids to mice.
G. Mainelis (2013)
10.1016/j.nano.2008.06.001
Drug delivery of siRNA therapeutics: potentials and limits of nanosystems.
D. Reischl (2009)
10.1016/S1461-5347(99)00209-6
Strategies for particle design using supercritical fluid technologies.
York (1999)
10.1016/j.drudis.2008.05.007
Chemically modified siRNA: tools and applications.
J. K. Watts (2008)
10.1038/nmat3765
Delivery materials for siRNA therapeutics.
R. Kanasty (2013)
Non-small cell lung carcinoma therapy using mTOR-siRNA.
H. Matsubara (2012)
10.2174/156720107782151269
Liposomal drug delivery systems: an update review.
A. Samad (2007)
10.14356/KONA.2016014
Aerosol Delivery of siRNA to the Lungs. Part 1: Rationale for Gene Delivery Systems.
Susanne R. Youngren-Ortiz (2016)
RNA interference : RNA
G. J. Hannon (2002)
10.1186/1741-7015-10-28
Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: the effect of combining RNA interference with tyrosine kinase inhibitors or cetuximab
G. Chen (2012)
10.1016/j.pupt.2010.03.007
RNAi-mediated suppression of constitutive pulmonary gene expression by small interfering RNA in mice.
B. Gutbier (2010)
10.1016/0005-2736(88)90077-6
Factors affecting the stability of dry liposomes.
J. Crowe (1988)
10.1093/TOXSCI/KFJ084
Research strategies for safety evaluation of nanomaterials, part V: role of dissolution in biological fate and effects of nanoscale particles.
P. Borm (2006)
10.1002/MASY.200900095
Pure Cellulose Nanoparticles from Trimethylsilyl Cellulose
Marc Kostag (2010)
10.1038/nrg1066
Progress and problems with the use of viral vectors for gene therapy
C. Thomas (2003)
10.1016/S0076-6879(09)64017-9
Engineering Cationic Liposome
Jennifer E. Podesta (2009)
10.1002/CPHC.200400527
Nanoparticles and nanocapsules created using the Ouzo effect: spontaneous emulisification as an alternative to ultrasonic and high-shear devices.
Ganachaud François (2005)
Chapter seventeen - engineering cationic liposome : siRNA complexes for in vitro and in vivo delivery
E. PodestaJ. (2009)
10.1186/ar2973
Attenuation of fibrosis in vitro and in vivo with SPARC siRNA
J. Wang (2010)
10.1002/1521-3900(200002)151:1<387::AID-MASY387>3.0.CO;2-D
Synthesis by interfacial polycondensation of polyamide capsules with various sizes. Characteristics and properties
L. Danicher (2000)
10.1021/MA8026244
One-Pot Synthesis of Hairy Nanoparticles by Emulsion ATRP
Ke Min (2009)
10.1016/j.jconrel.2010.02.006
Formulation, characterization and pulmonary deposition of nebulized celecoxib encapsulated nanostructured lipid carriers.
R. Patlolla (2010)
10.1186/1475-2867-13-8
Silencing SATB1 with siRNA inhibits the proliferation and invasion of small cell lung cancer cells
B. Huang (2012)
10.1002/POLA.21185
Singlewall carbon nanotubes covered with polystyrene nanoparticles by in-situ miniemulsion polymerization
Hyeong Taek Ham (2006)
10.1158/1078-0432.CCR-13-0073
RRM2 Regulates Bcl-2 in Head and Neck and Lung Cancers: A Potential Target for Cancer Therapy
M. Rahman (2013)
10.1089/HUM.2008.928
Delivery vehicles for small interfering RNA in vivo.
A. D. Fougerolles (2008)
10.1208/s12249-013-9988-3
Freeze-Dried Targeted Mannosylated Selenium-Loaded Nanoliposomes: Development and Evaluation
Susanne R. Youngren (2013)
Preparation of Chitosan Nanoparticles Loaded by Dexamethasone Sodium Phosphate
Amir Dustgani (2008)
10.1155/2014/734256
Optical and Structural Properties of ZnO Nanoparticles Synthesized by CO2 Microwave Plasma at Atmospheric Pressure
S. M. Chun (2014)
Bioconjugate techniques
G T Hermanson (2013)
10.1002/0471142700.nc0428s24
Disulfide Conjugation of Peptides to Oligonucleotides and Their Analogs
J. J. Turner (2006)
10.1016/S0169-409X(03)00041-3
Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications.
C. Vauthier (2003)
10.1016/j.jconrel.2012.06.005
An inhalable β₂-adrenoceptor ligand-directed guanidinylated chitosan carrier for targeted delivery of siRNA to lung.
Y. Luo (2012)
10.1016/j.jconrel.2009.11.008
Biodegradable calcium phosphate nanoparticle with lipid coating for systemic siRNA delivery.
J. Li (2010)
Research tool or therapeutic drug?
A De Fougerolles (2008)
10.1016/J.POLYMER.2007.09.039
Nanostructured latex particles synthesized by nitroxide-mediated controlled/living free-radical polymerization in emulsion
J. Nicolas (2007)
10.1166/JBN.2008.334
Inhaled Liposomes–Current Strategies and Future Challenges
M. Gaspar (2008)
10.1016/0378-5173(89)90281-0
Nanocapsule formation by interfacial polymer deposition following solvent displacement
H. Fessi (1989)
10.1023/A:1012128907225
Chitosan and Chitosan/Ethylene Oxide-Propylene Oxide Block Copolymer Nanoparticles as Novel Carriers for Proteins and Vaccines
P. Calvo (2004)
10.1166/JBN.2015.2145
Recent Developments in Active Tumor Targeted Multifunctional Nanoparticles for Combination Chemotherapy in Cancer Treatment and Imaging.
M. Glasgow (2015)
10.1002/ANIE.200352834
Supercritical-fluid processing technique for nanoscale polymer particles.
M. J. Meziani (2004)
Nano-liposomal dry powder inhaler of tacrolimus: Preparation, characterization, and pulmonary pharmacokinetics
M. Chougule (2007)
Liposome - A Novel Drug Delivery
Sayali V. Tarkunde (2014)
10.1016/J.POLYMER.2007.08.053
Comparison of RAFT polymerization of methyl methacrylate in conventional emulsion and miniemulsion systems
X. Zhou (2007)
10.1021/BI952436A
Potentiation of cationic liposome-mediated gene delivery by polycations.
X. Gao (1996)
10.1016/j.addr.2014.05.018
siRNA delivery to the lung: what's new?
O. Merkel (2014)
10.1038/mt.2009.271
RNAi-mediated CCR5 silencing by LFA-1-targeted nanoparticles prevents HIV infection in BLT mice.
Sang-soo Kim (2010)
10.1016/J.BIOMATERIALS.2005.09.005
Relationships between chemical composition, physical properties and transfection efficiency of polysaccharide-spermine conjugates.
H. Eliyahu (2006)
Codelivery of as-miR-21 and 5-FU by poly(amidoamine) dendrimer attenuates human glioma cell growth in vitro
Y. Ren (2010)
10.1016/j.addr.2011.02.006
Pulmonary delivery of therapeutic siRNA
J. K. Lam (2012)
10.1016/J.ADDR.2003.12.002
Solid lipid nanoparticles for parenteral drug delivery.
S. Wissing (2004)
10.1021/BC070012A
Dexamethasone-conjugated low molecular weight polyethylenimine as a nucleus-targeting lipopolymer gene carrier.
Yun Mi Bae (2007)
Author's short biography
RNAi-mediated CCR5 silencing by LFA-1targeted nanoparticles prevents HIV infection
S. S. Kim (2010)
10.1164/rccm.200807-1056OC
Ex vivo sputum analysis reveals impairment of protease-dependent mucus degradation by plasma proteins in acute asthma.
A. L. Innes (2009)
10.1016/S0928-0987(97)86243-4
Solid lipid nanoparticles (SLN) for controlled drug delivery
R. Mueller (1996)
10.1016/0378-5173(86)90236-X
Development of a new process for the manufacture of polyisobutylcyanoacrylate nanocapsules
N. A. K. Fallouh (1986)
Large-scale production of dsRNA and siRNA pools for RNA interference utilizing bacteriophage phi6 RNA-dependent RNA
A. P. Aalto (2007)
10.2174/1389200216666150206124913
Liposomes as siRNA delivery vectors.
S. Bochicchio (2014)
10.1016/S0009-2509(98)00083-9
New insights into kinetics and thermodynamics of interfacial polymerization
S. Karode (1998)
10.1016/S0169-409X(01)00105-3
Solid lipid nanoparticles: production, characterization and applications.
W. Mehnert (2001)
10.1385/1-59259-813-7:197
Synthesis of oligonucleotide-peptide and oligonucleotide-protein conjugates.
D. Corey (2004)
10.1038/mtna.2012.57
Pharmacological Characterization of a Novel ENaCα siRNA (GSK2225745) With Potential for the Treatment of Cystic Fibrosis
K. Clark (2013)
44–69 by a novel spontaneous emulsification solvent diffusion method
Susanne R. Youngren-Ortiz (2017)
10.1021/bm901298t
Computational insights into the interactions between DNA and siRNA with "rigid" and "flexible" triazine dendrimers.
G. M. Pavan (2010)
10.1002/(SICI)1097-4636(19991215)47:4<568::AID-JBM14>3.0.CO;2-X
Study of the mechanism of insulin encapsulation in poly(isobutylcyanoacrylate) nanocapsules obtained by interfacial polymerization.
M. Aboubakar (1999)
10.1038/icb.2011.41
Regulation of mucosal mast cell activation by short interfering RNAs targeting syntaxin4
S. Liu (2012)
10.1002/PAT.1646
Novel synthesis of polymer and copolymer nanoparticles by atomized microemulsion technique and its characterization
S. Mishra (2011)
10.1038/nature04303
Silencing of microRNAs in vivo with ‘antagomirs’
Jan Krützfeldt (2005)
Nitroxidemediated controlled/living free-radical surfactant-free emulsion polymerization of methyl methacrylate using a poly (methacrylic acid)-based macroalkoxyamine
C. Dire (2008)
10.1016/J.ADDR.2007.03.004
Exogenous siRNA delivery using peptide transduction domains/cell penetrating peptides.
Bryan R. Meade (2007)
10.1186/1465-9921-13-92
Gene expression profiling following NRF2 and KEAP1 siRNA knockdown in human lung fibroblasts identifies CCL11/Eotaxin-1 as a novel NRF2 regulated gene
J. Fourtounis (2012)
10.1038/nrg2006
Strategies for silencing human disease using RNA interference
D. Kim (2007)
10.1016/j.addr.2009.08.004
Chitosan-based formulations for delivery of DNA and siRNA.
S. Mao (2010)
10.1021/cr800242x
Controlled/living radical polymerization in dispersed systems.
P. Zetterlund (2008)
10.1021/MA802083G
Nitroxide-Mediated Controlled/Living Free-Radical Surfactant-Free Emulsion Polymerization of Methyl Methacrylate Using a Poly(methacrylic acid)-Based Macroalkoxyamine Initiator
Charlotte Dire (2009)
DIFFERENT TECHNIQUES FOR PREPARATION OF POLYMERIC NANOPARTICLES-A
H. K. Yadav (2012)
Author's short biography Susanne R
44–69 biomedical applications using the miniemulsion process
Susanne R. Youngren-Ortiz (2017)
10.1097/SHK.0b013e318254fa6a
The Role and Source of Tumor Necrosis Factor-&agr; in Hemorrhage-Induced Priming for Septic Lung Injury
Joanne L. Lomas-Neira (2012)
10.1038/35888
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans
A. Fire (1998)
10.1016/S0005-2736(00)00251-0
Stabilization of lipid/DNA complexes during the freezing step of the lyophilization process: the particle isolation hypothesis.
S. D. Allison (2000)
10.1164/rccm.201003-0422OC
RNA interference therapy in lung transplant patients infected with respiratory syncytial virus.
M. Zamora (2011)
10.1016/0378-5173(86)90125-0
Nanoparticles from microemulsions
M. Gasco (1986)
10.1007/s00018-005-5109-0
Cell-penetrating peptides: tools for intracellular delivery of therapeutics
S. Deshayes (2005)
Mesoporous silica nanoparticles for intracellular delivery of membraneimpermeable proteins
Slowing (2007)
10.1016/J.COLSURFA.2008.07.028
Core–shell biocompatible polyurethane nanocapsules obtained by interfacial step polymerisation in miniemulsion
F. Gaudin (2008)
10.1016/j.ijpharm.2008.10.003
Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products.
J. Pardeike (2009)
10.5772/58459
Liposomes as Potential Drug Carrier Systems for Drug Delivery
Melis Çağdaş (2014)
10.1021/JA046275M
A polyamidoamine dendrimer-capped mesoporous silica nanosphere-based gene transfection reagent.
D. R. Radu (2004)
Chapter seventeen-engineering cationic liposome: siRNA complexes for in vitro and in vivo
J. E. Podesta (2009)
10.1021/la803973p
Elucidating the encapsulation of short interfering RNA in PEGylated cationic liposomes.
K. Buyens (2009)
10.1016/j.antiviral.2007.11.009
Evaluation of the safety, tolerability and pharmacokinetics of ALN-RSV01, a novel RNAi antiviral therapeutic directed against respiratory syncytial virus (RSV).
J. Devincenzo (2008)
10.1021/IE010267M
Formation of perfluoropolyether coatings by the rapid expansion of supercritical solutions (RESS) process. Part 1: Experimental results
Yury I. Chernyak (2001)
10.1038/ncb2895
Stable RNA interference rules for silencing
Christof Fellmann (2013)
Relationships between chemical composition, physical properties and transfection efficiency of polysaccharide– spermine
H. Eliyahu (2006)
10.1016/j.febslet.2005.08.070
Approaches for chemically synthesized siRNA and vector‐mediated RNAi
Mohammed Amarzguioui (2005)
10.1016/j.ejpb.2011.10.021
Cellular uptake mechanism and knockdown activity of siRNA-loaded biodegradable DEAPA-PVA-g-PLGA nanoparticles.
M. Benfer (2012)
Liposome–a novel drug
S. V. Tarkunde (2014)
10.1016/S0014-5793(96)01397-X
Stabilization of cationic liposome‐plasmid DNA complexes by polyamines and poly(ethylene glycol)‐phospholipid conjugates for efficient in vivo gene delivery
K. Hong (1997)
10.1016/j.jconrel.2011.01.003
Development of a lyophilized plasmid/LPEI polyplex formulation with long-term stability--A step closer from promising technology to application.
J. C. Kasper (2011)
10.1016/J.ADDR.2012.09.021
Solid lipid nanoparticles
W. Mehnert (2012)
10.1016/0378-5173(93)90075-Q
Study of the mechanisms of formation of nanoparticles and nanocapsules of polyisobutyl-2-cyanoacrylate
M. Gallardo (1993)
10.1007/s00396-009-2087-z
Synthesis of phosphonate-functionalized polystyrene and poly(methyl methacrylate) particles and their kinetic behavior in miniemulsion polymerization
A. Ziegler (2009)
duced lung fibrosis
M. Zheng (2012)
Laura Espana-Serrano is a Research Associate in the Translational Drug Delivery Research laboratory in the department of Pharmaceutical Sciences of the Daniel K
Dr
10.1016/S0169-409X(00)00117-4
Panoparticulate systems for improved drug delivery.
Y. Kawashima (2001)
10.1021/MA0621932
Polymeric Nanoreactors for Hydrophilic Reagents Synthesized by Interfacial Polycondensation on Miniemulsion Droplets
D. Crespy (2007)
10.1002/POLA.23786
From Polymeric Particles to Multifunctional Nanocapsules for Biomedical Applications Using the Miniemulsion Process
K. Landfester (2010)
10.1073/PNAS.93.14.7305
Formation of stable cationic lipid/DNA complexes for gene transfer.
H. E. Hofland (1996)
10.1007/s11095-013-0984-9
Efficacy of Aerosolized Celecoxib Encapsulated Nanostructured Lipid Carrier in Non-small Cell Lung Cancer in Combination with Docetaxel
Apurva R. Patel (2013)
10.1038/aps.2012.39
siRNA against plasminogen activator inhibitor-1 ameliorates bleomycin-induced lung fibrosis in rats
Y. Zhang (2012)
10.1152/ajplung.00426.2012
Efficient delivery of RNA interference oligonucleotides to polarized airway epithelia in vitro.
S. Ramachandran (2013)
10.1158/1078-0432.CCR-06-2218
Potent siRNA Inhibitors of Ribonucleotide Reductase Subunit RRM2 Reduce Cell Proliferation In vitro and In vivo
J. Heidel (2007)
10.1016/j.coph.2008.04.005
siRNA and the lung: research tool or therapeutic drug?
A. D. de Fougerolles (2008)
10.1002/CHEM.200400422
Polymeric nanoparticles from rapid expansion of supercritical fluid solution.
Y. Sun (2005)
10.1165/rcmb.2011-0158OC
Development and preclinical efficacy of novel transforming growth factor-β1 short interfering RNAs for pulmonary fibrosis.
C. D’Alessandro-Gabazza (2012)
10.2147/IJN.S29152
Suppression of lung cancer progression by biocompatible glycerol triacrylate–spermine-mediated delivery of shAkt1
S. Hong (2012)
10.1016/j.ejpb.2013.08.013
Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC) for pulmonary application: a review of the state of the art.
S. Weber (2014)
The role and source of TNF-α in hemorrhage induced priming for septic lung injury
J. Lomas-Neira (2012)
10.2174/138161205774580769
Conjugates of oligonucleotides and analogues with cell penetrating peptides as gene silencing agents.
T. Zatsepin (2005)
Potentiation of cationic liposomemediated gene delivery by polycations, Biochemistry
X. Gao (1996)
10.1186/1471-2407-13-346
Abnormal expression of Pygopus 2 correlates with a malignant phenotype in human lung cancer
Y. Liu (2013)
10.1016/S0939-6411(00)00084-9
Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake?
T. Jung (2000)
10.1016/j.ejpb.2010.09.014
Chitosan-graft-spermine as a gene carrier in vitro and in vivo.
Hu-Lin Jiang (2011)
10.1016/j.addr.2009.03.003
Lipid-based systemic delivery of siRNA.
Yu Cheng Tseng (2009)
10.1007/s11095-008-9800-3
Methods for the Preparation and Manufacture of Polymeric Nanoparticles
C. Vauthier (2008)
Understanding the RESS process, Supercritical Fluid Technology in Materials Science and Engineering: Syntheses
M. Weber (2002)
10.1155/2013/858946
STAT6 siRNA Matrix-Loaded Gelatin Nanocarriers: Formulation, Characterization, and Ex Vivo Proof of Concept Using Adenocarcinoma Cells
Susanne R. Youngren (2013)
10.1016/J.SUPFLU.2006.04.003
Effect of material properties and processing conditions on RESS of poly(l-lactide)
A. Sane (2007)
10.1073/pnas.1004604107
Inhibition of lung tumor growth by complex pulmonary delivery of drugs with oligonucleotides as suppressors of cellular resistance
O. Garbuzenko (2010)
10.1002/JPS.1096
Maintenance of nonviral vector particle size during the freezing step of the lyophilization process is insufficient for preservation of activity: insight from other structural indicators.
M. Molina (2001)
10.1208/s12248-009-9140-1
Lipidic Systems for In Vivo siRNA Delivery
S. Wu (2009)
44–69 peptides: Tools for intracellular delivery of therapeutics
Susanne R. Youngren-Ortiz (2017)
44–69 ratory syncytial virus
Susanne R. Youngren-Ortiz (2017)
10.1081/DDC-100102197
Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method.
J. Barichello (1999)
10.1002/MARC.200500438
Novel Semiconducting Polymer Particles by Supercritical Fluid Process
K. Lim (2005)
10.1002/JPS.2600830527
In vitro drug release behavior of D,L-lactide/glycolide copolymer (PLGA) nanospheres with nafarelin acetate prepared by a novel spontaneous emulsification solvent diffusion method.
T. Niwa (1994)
10.1023/A:1007504613351
Oxygen Radical-Mediated Pulmonary Toxicity Induced by Some Cationic Liposomes
Sujatha Dokka (2004)
10.1002/cmdc.201100259
Hydrophobic Oxime Ethers: A Versatile Class of pDNA and siRNA Transfection Lipids
Souvik Biswas (2011)
10.1038/nm1164
Inhibition of respiratory viruses by nasally administered siRNA
V. Bitko (2005)
10.1371/journal.pone.0077121
Knockdown of the Sodium-Dependent Phosphate Co-Transporter 2b (NPT2b) Suppresses Lung Tumorigenesis
S. Hong (2013)
Nanoparticles and nanocapsules created using the ouzo effect: Spontaneous emulsification as an alternative to ultrasonic and high shear devices, ChemPhysChem
F. Ganachaud (2005)
Relationships between chemical composition, physical properties and transfection efficiency of polysaccharidespermine conjugates
H Eliyahu (2006)
10.1002/POL.1982.130201006
On the mechanism of termination in heterogeneous polymerization
J. Kreuter (1982)
10.1016/j.jconrel.2011.08.011
Design of an inhalable dry powder formulation of DOTAP-modified PLGA nanoparticles loaded with siRNA.
D. K. Jensen (2012)
10.1016/j.biomaterials.2013.05.082
Dexamethasone-conjugated polyethylenimine/MIF siRNA complex regulation of particulate matter-induced airway inflammation.
M. Choi (2013)
10.1016/0378-5173(95)00142-6
Influence of the preparation conditions on poly(ethylcyanoacrylate) nanocapsule formation
G. Puglisi (1995)
10.1016/j.earlhumdev.2009.08.013
Harnessing RNA interference to develop neonatal therapies: from Nobel Prize winning discovery to proof of concept clinical trials.
J. Devincenzo (2009)
10.1016/S0005-2736(00)00343-6
Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: formation of novel small multilamellar vesicle structures.
S. Semple (2001)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar